Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Head and Neck Cancer
Interventions
DIETARY_SUPPLEMENT

oral glutamine

L-Glutamine and maltodextrin are both nutritional supplements. In the glutamine arm: 10 g L-Glutamine and 5 g maltodextrin. The patients take their supplements three times a day during the period: 7 days before radiotherapy to 14 days after radiotherapy.

DIETARY_SUPPLEMENT

placebo

in the placebo arm: 15 g maltodextrin. The patients take their supplements three times a day during the period: 7 days before radiotherapy to 14 days after radiotherapy.

RADIATION

Radiotherapy

All patients undergo radiotherapy. 5 days a week. All patients had a dental evaluation for good oral hygiene prior to computed tomography simulation for radiotherapy. Post-operative patients received planned course of adjuvant treatment of 60 to 66 Gy in 2-Gy fractions to the surgical bed. The course of radiation was initiated no more than 6 weeks after resection. Patients without operation received definitive treatment to 70 Gy in 2-Gy fractions.

Trial Locations (1)

80708

Kaohsihung Medical University Hospital, Kaohsiung City

All Listed Sponsors
lead

Kaohsiung Medical University Chung-Ho Memorial Hospital

OTHER

NCT03015077 - Effects of Oral L-Glutamine in Head and Neck Cancer Patients During Radiotherapy | Biotech Hunter | Biotech Hunter